文献速递垂体与肾上腺疾病

免疫检查点抑制剂诱导的继发性肾上腺皮质功能不全患者生活质量的决定因素

Determinants of quality of life in patients with immune checkpoint inhibitor-induced secondary adrenal insufficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

单中心横断面研究纳入109例ICI-SAI和139例其他病因继发性肾上腺皮质功能不全患者,比较生活质量与肾上腺危象。AddiQoL评分越高,肾上腺危象风险越低(OR 0.57,95%CI 0.42-0.76)。

要点

  • ICI-SAI患者生活质量优于其他病因SAI患者。
  • 两组肾上腺危象发生率相似。
  • 较高AddiQoL评分与较低肾上腺危象风险独立相关。

核心结论

  • ICI-SAI患者报告的生活质量优于其他病因继发性肾上腺皮质功能不全患者,尽管肾上腺危象发生率相似。

研究设计与样本

  • 单中心横断面研究,纳入2018-2025年成人ICI-SAI患者109例和其他病因继发性肾上腺皮质功能不全患者139例,完成AddiQoL问卷。

主要发现

  • 多变量分析中,较高AddiQoL评分与较低肾上腺危象风险独立相关(OR 0.57;95%CI 0.42-0.76)。

临床怎么用

  • 对ICI-SAI患者应关注生活质量评估和肾上腺危象预防。
  • 早期识别和以患者为中心的管理可能改善结局。

局限性

  • 单中心横断面设计可能限制因果推断和普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Limited data are available on quality of life (QoL) and adrenal crises in patients with immune checkpoint inhibitor-induced secondary adrenal insufficiency (ICI-SAI). OBJECTIVE: To (1) characterize the presentation, management, and outcomes of patients with ICI-SAI; (2) compare outcomes of ICI-SAI with other etiologies of secondary adrenal insufficiency (oSAI); and (3) identify variables associated with QoL and adrenal crisis. METHODS: In this single-center cross-sectional study, adults with ICI-SAI or oSAI (2018-2025) completed questionnaires assessing symptoms, management, adrenal crises, and the Addison's Disease-Specific QoL survey (AddiQoL); outcomes included AddiQoL score and adrenal crisis events. RESULTS: Patients with ICI-SAI (n = 109) were older (median age 66 vs 60 years), more often women (59% vs 43%), and more frequently diagnosed within 1 year of symptom onset (88% vs 42%, P < .001), compared to patients with oSAI (n = 139). Patients with ICI-SAI had higher AddiQoL scores (median 87 vs 85, P = .020). In a multivariable analysis of age, sex, glucocorticoid dose and type, insurance support, and duration of SAI, ICI-SAI remained independently associated with higher AddiQoL (estimate 5.4, P = .010). The prevalence of reported adrenal crises within the prior year was similar between groups (15% vs 14%, P = .782). In a multivariable analysis, higher AddiQoL scores were independently associated with lower odds of adrenal crisis (OR 0.57; 95% CI 0.42-0.76). CONCLUSION: Patients with ICI-SAI report better QoL compared with patients with other causes of SAI, despite similar adrenal crisis rates. These differences may be related to earlier diagnosis and differing clinical contexts, underscoring the importance of timeline recognition and patient-centered management.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Herndon J, Hleibiehova Y, Achenbach SJ, et al. Determinants of quality of life in patients with immune checkpoint inhibitor-induced secondary adrenal insufficiency. J Clin Endocrinol Metab. 2026. PMID: 42212516. doi:10.1210/clinem/dgag219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。